Literature DB >> 11802585

The Vaccine Safety Datalink project.

F DeStefano1.   

Abstract

The Vaccine Safety Datalink (VSD) is a collaborative project between the National Immunization Program of the Centers for Disease Control and Prevention (CDC) and several large health maintenance organizations (HMOs) in the United States. The project began in 1990 with the primary purpose of rigorously evaluating concerns about the safety of vaccines. Computerized data on vaccination, medical outcome (e.g. hospital discharge, outpatient visits, emergency room visits, and deaths), and covariate data (e.g. birth certificates and census) are prospectively collected at multiple HMOs (initially four) and linked under joint protocol for analyses. Approximately 6 million people (2% of the US population) are members of HMOs participating in the VSD. The VSD has proven to be a valuable resource that has provided important information on a number of vaccine safety issues. The databases and infrastructure created for the VSD have also provided opportunities to address other immunization questions including vaccination coverage and cost-effectiveness. In a recent investigation of intussusception following rotavirus vaccination, the VSD methodology was expanded to include 10 managed care organizations. A cohort study was conducted that allowed estimation of incidence rates of intussusception and attributable risks associated with rotavirus vaccine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11802585     DOI: 10.1002/pds.613

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  26 in total

1.  Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010.

Authors:  Sharon K Greene; Melisa Rett; Eric S Weintraub; Lingling Li; Ruihua Yin; Anthony A Amato; Doreen T Ho; Sarah I Sheikh; Bruce H Fireman; Matthew F Daley; Edward A Belongia; Steven J Jacobsen; Roger Baxter; Tracy A Lieu; Martin Kulldorff; Claudia Vellozzi; Grace M Lee
Journal:  Am J Epidemiol       Date:  2012-05-11       Impact factor: 4.897

2.  Compliance with multiple-dose vaccine schedules among older children, adolescents, and adults: results from a vaccine safety datalink study.

Authors:  Jennifer C Nelson; Rachel C L Bittner; Lora Bounds; Shanshan Zhao; James Baggs; James G Donahue; Simon J Hambidge; Steven J Jacobsen; Nicola P Klein; Allison L Naleway; Kenneth M Zangwill; Lisa A Jackson
Journal:  Am J Public Health       Date:  2009-10       Impact factor: 9.308

3.  Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project.

Authors:  Sharon K Greene; Martin Kulldorff; Edwin M Lewis; Rong Li; Ruihua Yin; Eric S Weintraub; Bruce H Fireman; Tracy A Lieu; James D Nordin; Jason M Glanz; Roger Baxter; Steven J Jacobsen; Karen R Broder; Grace M Lee
Journal:  Am J Epidemiol       Date:  2009-12-04       Impact factor: 4.897

4.  Drug-induced aseptic meningitis: 329 cases from the French pharmacovigilance database analysis.

Authors:  Kevin Bihan; Nicolas Weiss; Hélène Théophile; Christian Funck-Brentano; Bénédicte Lebrun-Vignes
Journal:  Br J Clin Pharmacol       Date:  2019-08-01       Impact factor: 4.335

5.  Vaccines don't save lives. Vaccinations save lives.

Authors:  Walter Orenstein
Journal:  Hum Vaccin Immunother       Date:  2019-11-08       Impact factor: 3.452

6.  Surveillance for Guillain-Barré syndrome after influenza vaccination among the Medicare population, 2009-2010.

Authors:  Dale R Burwen; Sukhminder K Sandhu; Thomas E MaCurdy; Jeffrey A Kelman; Jonathan M Gibbs; Bruno Garcia; Marianthi Markatou; Richard A Forshee; Hector S Izurieta; Robert Ball
Journal:  Am J Public Health       Date:  2012-02-16       Impact factor: 9.308

Review 7.  Improving postapproval drug safety surveillance: getting better information sooner.

Authors:  Sean Hennessy; Brian L Strom
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-09-25       Impact factor: 13.820

8.  Vaccination Patterns in Children After Autism Spectrum Disorder Diagnosis and in Their Younger Siblings.

Authors:  Ousseny Zerbo; Sharareh Modaressi; Kristin Goddard; Edwin Lewis; Bruce H Fireman; Matthew F Daley; Stephanie A Irving; Lisa A Jackson; James G Donahue; Lei Qian; Darios Getahun; Frank DeStefano; Michael M McNeil; Nicola P Klein
Journal:  JAMA Pediatr       Date:  2018-05-01       Impact factor: 16.193

9.  Uptake of meningococcal conjugate vaccine among adolescents in large managed care organizations, United States, 2005: demand, supply and seasonality.

Authors:  Suchita A Lorick; Daniel Fishbein; Eric Weintraub; Pascale M Wortley; Grace M Lee; Fangjun Zhou; Robert Davis
Journal:  BMC Infect Dis       Date:  2009-11-03       Impact factor: 3.090

10.  Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study.

Authors:  Lisa A Jackson; Onchee Yu; Edward A Belongia; Simon J Hambidge; Jennifer Nelson; Roger Baxter; Allison Naleway; Charlene Gay; James Nordin; James Baggs; John Iskander
Journal:  BMC Infect Dis       Date:  2009-10-05       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.